key: cord-0926153-rqiun0vw
authors: Conway, Richard P.; Byrne, Declan G.; O’Riordan, Deirdre M. R.; Kent, Brian D.; Kennedy, Barry M. J.; Cheallaigh, Clíona M. Ní; O’Connell, Brian P.; Akasheh, Nadim B.; Browne, Joseph G.; Silke, Bernard M.
title: Emergency medical admissions and COVID-19: impact on 30-day mortality and hospital length of stay
date: 2021-08-30
journal: Ir J Med Sci
DOI: 10.1007/s11845-021-02752-7
sha: c1e91dadb8cd35cf6653e41483b716b0a718903e
doc_id: 926153
cord_uid: rqiun0vw

BACKGROUND: The COVID-19 pandemic has put considerable strain on healthcare systems. AIM: To investigate the effect of the COVID-19 pandemic on 30-day in-hospital mortality, length of stay (LOS) and resource utilization in acute medical care. METHODS: We compared emergency medical admissions to a single secondary care centre during 2020 to the preceding 18 years (2002–2019). We investigated 30-day in-hospital mortality with a multiple variable logistic regression model. Utilization of procedures/services was related to LOS with zero truncated Poisson regression. RESULTS: There were 132,715 admissions in 67,185 patients over the 19-year study. There was a linear reduction in 30-day in-hospital mortality over time; over the most recent 5 years (2016–2020), there was a relative risk reduction of 36%, from 7.9 to 4.3% with a number needed to treat of 27.7. Emergency medical admissions increased 18.8% to 10,452 in 2020 with COVID-19 admissions representing 3.5%. 18.6% of COVID-19 cases required ICU admission with a median stay of 10.1 days (IQR 3.8, 16.0). COVID-19 was a significant univariate predictor of 30-day in-hospital mortality, 18.5% (95%CI: 13.9, 23.1) vs. 3.0% (95%CI: 2.7, 3.4)—OR 7.3 (95%CI: 5.3, 10.1). ICU admission was the dominant outcome predictor—OR 12.4 (95%CI: 7.7, 20.1). COVID-19 mortality in the last third of 2020 improved—OR 0.64 (95%CI: 0.47, 0.86). Hospital LOS and resource utilization were increased. CONCLUSION: A diagnosis of COVID-19 was associated with significantly increased mortality and LOS but represented only 3.5% of admissions and did not attenuate the established temporal decline in overall in-hospital mortality.

Coronavirus disease 2019 (COVID-19) has caused high rates of critical illness and mortality [1, 2] with burdens placed on national healthcare systems. Case fatality rates for COVID- 19 have varied dramatically worldwide, perhaps because of differences in populations, public health, and healthcare systems [3] ; it appears also that outcomes may have improved over time [4] . In acute medicine, the COVID-19 pandemic led to a major reorganization of in-hospital care with substantial restrictions, either provider-imposed or consumer reactive, on non-COVID-19 attendance and admissions [5] .

Staffing rotas have been reconfigured, with attempted higher levels of consultant presence to anticipate the effect of radical reorganization of care on admission and discharge patterns [5] .

Much attention has been centred on the question of underlying comorbidity and its impact; meta-analysis has suggested that specific conditions such as cardiovascular disease predispose to worse outcomes [6] . The importance of illness severity at presentation has not been reported previously [7] . In this paper, we examine the impact of the first year of the COVID-19 epidemic on the demographics and outcomes of emergency medical admissions overall, and specifically explore factors associated with outcomes in those with a diagnosis of COVID-19.

St. James's Hospital, Dublin, serves as a secondary care centre for emergency admissions in a catchment area with a population of 270,000 adults. St. James is based in an inner city area with an ageing population and high intrinsic rates of deprivation and comorbidity [7, 8] . All emergency medical admissions are admitted from the emergency department (ED) to an acute medical admission unit (AMAU), the operation and outcome of which have been described elsewhere [9] [10] [11] [12] . There were changes to this model of care during the COVID-19 pandemic, primarily with COVID-19 patients being admitted to designated wards; non-COVID-19 patients continued to follow the above model. The current study evaluates all emergency medical admissions between 2002 and 2020.

An anonymous patient database was employed, assembling core information from each clinical admission including details from the patient administration system, the national hospital in-patient enquiry (HIPE) scheme, the patient electronic record, and the laboratory data. HIPE is a national database of coded discharge summaries from acute public hospitals in Ireland [13] . The International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) has been used for both diagnosis and procedure coding from 1990 to 2005 and ICD-10-CM since then. Data included parameters such as the unique hospital number, admitting consultant, date of birth, gender, area of residence, principal and up to nine additional secondary diagnoses, principal and up to nine additional secondary procedures, and admission and discharge dates. Additional information cross-linked and automatically uploaded to the database includes physiological, haematological, and biochemical parameters.

Derangement of admission biochemical parameters may be utilized to predict clinical outcome. We have previously derived and applied an Acute Illness Severity Score (AISS) [14] , predicting 30-day in-hospital mortality from parameters recorded in the ED. A weighted age adjusted score was derived; six risk groups (I-VI) were identified with cut-points for 30-day in-hospital mortality set at 1, 2, 4, 8, and 16%. We further adjusted for comorbidity as described below. In addition, categories of (1) no blood culture request, (2) negative blood culture, and (3) positive blood culture were identified and used as an adjustor in the multivariable logistic regression model [15] .

Patient morbidity was assessed by a comorbidity score [7] . To devise the score, we searched ICD Codes that captured chronic physical or mental health disorders that limit people in activities that they generally would be expected to be able to perform were grouped according to the following ten systems: (i) cardiovascular, (ii) respiratory, (iii) neurological, (iv) gastrointestinal, (v) diabetes, (vi) renal, (vii) neoplastic disease, (viii) others (including rheumatological disabilities), (ix) ventilatory assistance required, and (x) transfusion requirement. In addition, we searched our hospital's other databases for evidence of diabetes (Diamond database) [16] , respiratory insufficiency (FEV1 < 2 L), troponin status (high sensitivity troponin ≥ 25 ng/L) [17] , low albumin (< 35 G/ dL), and anaemia (haemoglobin levels < 10 G/dL) or chronic renal insufficiency-MDRD < 60 mL/min * 1.73 m 2 [18] . Each component of the score was then weighted according to 30-day in-hospital mortality.

Descriptive statistics were calculated for background demographic data, including means/standard deviations (SD), medians/inter-quartile ranges (IQR), or percentages. Comparisons between categorical variables and mortality were made using chi-square tests. We adjusted the outcome computation (30-day in-hospital mortality) for other known predictor variables including AISS [14] , comorbidity score [7] , and blood culture results [15] . Thirty-day in-hospital mortality is defined as a death occurring for any reason in the hospital within 30 days of the admission date. We employed a logistic model with robust estimate to allow for clustering; the correlation matrix thereby reflected the average discrete risk attributable to each of these predictor variables [14] . Of course, over a prolonged observation period of 19 years, many patients were admitted more than once. For example, those admitted more than one, two, or three times were 49.5%, 31.8%, and 22.4%, respectively, with 5.4% admitted > 10 times each. Clearly, there will be a difference in mortality rates if calculated by admission or by patient (only last admission considered if > 1); we specifically state the calculation basis throughout.

Logistic regression analysis identified potential mortality predictors and then tested those that proved to be significant univariate predictors (p < 0.1 by Wald test) to ensure that the model included all variables with predictive power. We used the margin command in Stata to estimate and interpret adjusted subgroup predictions controlling for other variables, using computations of average marginal effects. Margins are statistics calculated from predictions of a previously fitted model at fixed values of some covariates and averaging or otherwise over the remaining covariates.

We were interested to determine whether COVID-19 status, due to case complexity and an extended hospital stay, might be associated with additional investigations. We quantitated in-hospital procedures during each admission, including allied service utilization (physiotherapy, speech and language, dietetics, social, occupational therapy, and psychiatric attendance) and interventions including ventilation, bronchoscopy, GI endoscopy/colonoscopy, and coronary angiography. We regressed the sum of these against hospital length of stay (LOS), using truncated Poisson regression, by COVID-19 status. The dependent variable of LOS is restricted to certain values; the predictor variables were therefore regressed against LOS using the truncated Poisson model. We used robust standard errors for the parameter estimates, as recommended by Cameron and Trivedi [19] . The Poisson regression coefficients are the log of the rate ratio: one can interpret the coefficients in terms of incidence rate ratios (IRR).

Adjusted odds ratios (OR) and 95% confidence intervals (CI) were calculated for those predictors that significantly entered the model (p < 0.10). Statistical significance at p < 0.05 was assumed throughout. Stata v.16 (Stata Corporation, College Station, TX) statistical software was used for analysis.

There were a total of 132,715 emergency medical admissions in 67,185 patients over the 19-year study period (2002-2020). Total emergency medical hospital admissions increased from 5476 in 2002 to 8485 in 2019 (+ 54.9%) with a further increase in 2020 to 10,452 (+ 18.8% increase vs. 2019). However, COVID-19 cases only represented 3.5% of admissions in 2020 (n = 361; Table 1 ). The total number of COVID-19 hospital admissions in Ireland in 2020 was 5985 (https:// www. gov. ie/ en/ press-relea se/ 166a4-state mentfrom-the-natio nal-public-health-emerg ency-team-thurs day-31-decem ber/ 

The long-term trend of reduction in 30-day in-hospital mortality, year on year, was uninterrupted by COVID-19 admissions. However, COVID-19 cases only represented 3.5% of the 10,452 admissions in 2020; the higher mortality with a COVID-19 admission was insufficient to impact the linear decrease in 30-day in-hospital mortality over time (Fig. 1) . As calculated per patient, the 30-day in-hospital mortality over the 19-year period averaged at 8.7% (95%CI 

LOS was considerably extended for COVID-19 admissions (Fig. 3) . COVID-19-positive admissions were, after adjustment for case complexity (AISS, comorbidity score, Charlson index, blood culture results), more likely to have an extended LOS-IRR 1.43 (95%CI: 1.32, 1.56) (p = 0.001).

There was a linear relationship between the hospital LOS and the number of procedures/interventions, when unadjusted for case complexity: IRR 1.34 (95%CI: 1.32, 1.36) (p < 0.001) (Fig. 4 ).

We have demonstrated several important findings in this single-centre study. COVID-19 admissions represented 3.5% of admissions in 2020. Contrary to the expressed view that non-COVID admissions would decrease during the pandemic due to patients avoiding the ED, we have demonstrated an increase in non-COVID emergency medical admissions in the same time frame. COVID-19 admissions were associated with greatly increased 30-day in-hospital mortality and length of stay. Clinical mortality outcomes of COVID-19 admissions improved significantly over time, with mortality decreasing by 36% later in 2020; this may relate to both greater experience in treating COVID-19 and the clinical implementation of the proven benefit of glucocorticoids in COVID-19 [20, 21] .

There is a view that COVID-19 patients have a high mortality due to underlying comorbidity such as COPD, cardiovascular or cerebrovascular disease, and diabetes [6] . Our data includes a measure of the admission illness severity [14] , predicting 30-day in-hospital mortality from parameters recorded in the ED [22] . This is a weighted measure of the disturbance in biochemistry and reflects the extent of the failure of homeostatic compensation. It is a not routine parameter available as a model adjustor, unlike comorbidity which is generally derived from ICD Codes such as the Charlson comorbidity index [23] , when modelling and relating to mortality outcomes. If it were the case that comorbidity is a substantial determinant of mortality outcomes, then one would anticipate curves close together a low morbidity, with separation as the comorbidity burden increased; our data ( Fig. 1) showed no such trend with parallel curves. Overall, COVID-19 cases had worse outcomes than non-COVID-19 admissions; the adjusted multiple variable model prediction for 30-day hospital mortality was 11.4% vs. 3.6%-a 3.2-fold increase after adjustment for case complexity and comorbidity. However, although major predictors of comorbidity, illness severity, and blood culture results were all individually predictive, the interaction function indicated that the independent underlying predictor was illness severity (high AISS); AISS was the only predictor remaining significant in the full model, including prediction interactions.

The overall mortality rate cited in earlier series of hospitalized patients with COVID-19 was 11-15%, but the later experience suggested a fall to 2-3% [24] ; these figures are very far from our data. Of course, comparing death rates across populations is problematic with social determinants of health contributed to differential mortality rates. In Brazil, older persons > 70 years had a greater than 55% mortality that fell to 12% in patients younger than 40 years [25] . However, some very large temporal mortality reductions in older UK adults across the early pandemic were suggested, with more than a 50% decrement in patients older than 80 years [26] ; Canadian experience suggests a substantial fall month on month, from 25.6 to 7.6% [4] . Other UK experience has suggested an 11·8% [27] . We would feel that a modeladjusted fall of the order of 30% would be substantial and consistent with reasonable expectations; a model outcome prediction tool for COVID-19 with laboratory elements appears to have similar predictive mortality rates related to a similar range of computed scores to our data [28] .

In terms of resource utilization, adjusted for case complexity and comorbidity, COVID-19 admissions had a more extended hospital episode (+ 26%) with increased demand on hospital procedures and services (+ 34%). We have shown a significant increase in non-COVID emergency medical admissions in 2020, in contrast to reports from elsewhere [29, 30] . Crisis planning resulting in the recruitment of more participating consultants and specialities into the admitting acute medicine service in our institution may have adjusted upwards somewhat the numbers of patients classified as emergency medical admissions, but a + 22.8% increase vs. 2019 in volume with the added burden of COVID-19 appears a very large additionality for the acute medicine service. It is possible that limitations in access to scheduled care services resulted in more emergency medical admissions as this was sometimes the only route of care access remaining functional during the pandemic. It will be interesting to see whether this augmentation in admission volume represents a transient phenomenon.

There are some limitations to our current analysis. Our study was conducted in a single large academic teaching hospital serving an urban area with a population with high deprivation; our results require replication in other centres and settings to confirm the external validity of our findings [8, 31, 32] . We have adjusted for a large number of potential outcome predictors in our multiple variable models: however, it is possible that residual unmeasured confounders remain. There may have been overfitting of our models; however, the large numbers of cases included mitigates against this. It is impossible to fully remove the effects of COVID-19 from the dramatic restructuring of care which happened due to the crisis management of the situation and this may have had unpredictable additional effects on outcomes [32] . Our database collects extensive information on all medical admissions; however, certain variables which have been shown to be risk factors for poor COVID outcomes, including BMI and ethnicity, are not included. Our study included data until the end of 2020, encompassing the first two waves of COVID-19 in Ireland; it is possible that the third wave of COVID-19 in early 2021 may have had a different impact and this should be assessed in future studies.

In conclusion, we have demonstrated that COVID-19 admissions have a significantly increased mortality and hospital length of stay. Outcomes in patients with COVID-19 appear to be mediated by illness severity rather than comorbidity or other predictors.

Sixty-day outcomes among patients hospitalized with COVID-19

Clinical characteristics of Covid-19 in New York City

Characteristics and outcomes of hospital admissions for COVID-19 and influenza in the Toronto area

Trends in COVID-19 risk-adjusted mortality rates

Rhythmicity of patient flow in an acute medical unit: relationship to hospital occupancy, 7-day working and the effect of COVID-19

Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis

Comparative influence of Acute Illness Severity and comorbidity on mortality

Deprivation as an outcome determinant in emergency medical admissions

Outcomes in acute medicine-evidence from extended observations on readmissions, hospital length of stay and mortality outcomes

Fifteen-year outcomes of an acute medical admission unit

Long-term outcome of an AMAU-a decade's experience

Does admission via an acute medical unit influence hospital mortality? 12 years' experience in a large Dublin hospital

A critical evaluation of HIPE data

An improved medical admissions risk system using multivariable fractional polynomial logistic regression modelling

Prognostic value of blood cultures as an illness severity marker in emergency medical admissions

Application of database systems in diabetes care

High-sensitivity troponin as an outcome predictor in acute medical admissions

Using the MDRD value as an outcome predictor in emergency medical admissions. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association

Microeconometrics using stata

Dexamethasone in hospitalized patients with Covid-19

Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

The outbreak of COVID-19: an overview

Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data

Patient factors and temporal trends associated with COVID-19 in-hospital mortality in England: an observational study using administrative data

Trends in intensive care for patients with COVID-19 in England, Wales, and Northern Ireland

Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score

The demand for hospital emergency services: trends during the first month of COVID-19 response

Projected impact of COVID-19 mitigation strategies on hospital services in the Mexico City Metropolitan Area

Deprivation index and dependency ratio are key determinants of emergency medical admission rates

Influence of social deprivation, overcrowding and family structure on emergency medical admission rates

Targets and the emergency medical system-intended and unintended consequences

Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations

Acknowledgements We wish to recognize the contribution of our consultant medical colleagues and the non-consultant members of the 'on-call' teams without which the AMAU initiative could not have progressed. The dedicated contribution the Clinical Nurse Managers and the ancillary professions related to medicine (SCOPE) is gratefully acknowledged.

Funding Open Access funding provided by the IReL Consortium.

No further data is available for sharing. All pertinent data have been published in this manuscript.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http:// creat iveco mmons. org/ licen ses/ by/4. 0/.